We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Effects of nicorandil on myocardial infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: study design and protocol for the randomized controlled trial.
- Authors
Xiao-Si JIANG; Li-Chao TIAN; Zi-Chao JIANG; Yu-Ting ZOU; Ping LI; Xin-Chun YANG; Xi SU; Jin-Wen TIAN; Bei SHI; Zong-Zhuang LI; Yong-Jun LI; Ren-Qiang YANG; Geng QIAN; Yun-Dai CHEN
- Abstract
Previous studies have shown that nicorandil has a protective effect on cardiomyocytes. However, there is no study to investigate whether perioperative intravenous nicorandil can further reduce the myocardial infarct size in patients with ST-segment elevation myocardial infarction (STEMI) compared to the current standard of percutaneous coronary intervention (PCI) regimen. The CHANGE (China-Administration of Nicorandil Group) study is a multicenter, prospective, randomized, double-blind and parallel-controlled clinical study of STEMI patients undergoing primary PCI in China, aiming to evaluate the efficacy and safety of intravenous nicorandil in ameliorating the myocardial infarct size in STEMI patients undergoing primary PCI and provide evidence-based support for myocardial protection strategies of STEMI patients.
- Subjects
CHINA; NICORANDIL; CARDIOVASCULAR diseases; MYOCARDIAL infarction; PERCUTANEOUS coronary intervention
- Publication
Journal of Geriatric Cardiology, 2020, Vol 17, Issue 8, p519
- ISSN
1671-5411
- Publication type
Article
- DOI
10.11909/j.issn.1671-5411.2020.08.002